Clinical Studies Results show Immune Function Can Be Improved by Consumption of DuPont™ Probiotic Strain Bifidobacterium lactis Bi-07


A collaborative study by DuPont Nutrition & Health and the University of Reading (UK) on the effect of probiotic Bifidobacterium lactis Bi-07™ on immune function in healthy elderly subjects has been published in the Journal of Nutritional Science.

The results of this study found that consumption of the probiotic Bifidobacterium lactis Bi-07™ improves the function of specialized innate immune cells, the phagocytes, in elderly subjects. The elderly commonly have reduced immune function and this physiological effect may thus contribute to a better maintenance of their health.

“Immunity continues to be one of the main fields of research for DuPont N&H. Alterations in the gut microbiota and immune functions of elderly adults are associated with higher susceptibility to infections and metabolic disorders,” said Dr. Markus Lehtinen, senior scientist, DuPont Nutrition & Health.

“Phagocytosis, by which immune cells ‘eat’ bacteria or infected cells, is one of the mechanisms that help to resist infections. Results of this study show that the probiotic Bi-07™ may provide health benefits to elderly individuals by increasing the activity of phagocytic cells.”

Study Design
Upon completion of a screening process, 40 healthy elderly volunteers were found to be eligible for the study and were randomly divided into four groups. A double-blinded, placebo-controlled, randomized cross-over study was designed in which volunteers received maltodextrin as a placebo (8 g/d), prebiotic galacto-oligosaccharides (GOS) (8 g/d), probiotic (Bi-07™; 109 colony-forming units/d) and synbiotic GOS + Bi-07™ (8 g GOS/d and 109 colony-forming units Bi-07™/d).

Daily portions were based on dose-response clinical studies showing that an 8 g portion of GOS increases the number of bifidobacteria in the intestine, and that 109 colony-forming units of B. lactis induce changes in elderly microflora. Volunteers were randomized to four groups that consumed the study products in random order in four periods. Supplements were provided for 21 days, with a 28-day wash-out period that has been effective in previous studies with B. lactis and GOS.

Study Data
Blood, saliva and fecal samples were taken from the study subjects to analyze markers of immune function and microbiota composition. The phagocytic activity was analyzed using fluorescent bacteria that were incubated in blood samples containing phagocytes. The number of bacteria in the phagocytes was detected by using flow cytometry.

Primary statistical analysis revealed carry-over effects, which had the potential to bias results, and thus the statistical analysis was conducted for parallel groups using results from samples obtained on day 0 (before the first supplementation) and on day 21 (after the first supplementation period). It was found that subjects in the Bi-07™ group had higher phagocytic activity of monocytes (p<0.001) and granulocytes (p=0.02) than subjects in the placebo group. Changes in other markers of immune function or microbiota composition were not detected in any supplementation groups.

Key Findings
The investigators found that the 28-day wash-out period for GOS and Bi-07™ was not sufficient in this elderly population, although previously it has been found useful for adult populations. This finding indicates that results on probiotic and prebiotic interventions may not be extrapolated from one population to another that differs in microbiota and immune function.

Researchers concluded that Bi-07™ consumption improved innate phagocytic activity of monocytes and granulocytes in healthy elderly. This could be beneficial to elderly who suffer from decreased phagocytic activity and higher susceptibility to infections. Supplementation with GOS or with the synbiotic combination of GOS and Bi-07™ did not have an impact on any of the parameters that were measured.

Focus on Health    
The combined resources within DuPont Nutrition & Health help manufacturers create products with a healthier profile, and that actively promote good health, to address consumer needs in digestive health, immune health, heart health, muscle health and weight management. The company’s capabilities are applied with a focus on the specific needs of key industry segments, including bakery, beverages, bars and snacks, dairy, meat, ready meals, pediatric nutrition and dietary supplements. DuPont N&H recently launched its new Howaru® Protect probiotic range to address the need for improved immunity in different consumer segments.



DuPont Nutrition & Health addresses the world’s challenges in food by offering a wide range of sustainable, bio-based ingredients and advanced molecular diagnostic solutions to provide safer, healthier and more nutritious food.  Through close collaboration with customers, DuPont combines knowledge and experience with a passion for innovation to deliver unparalleled customer value to the marketplace. More information is available at

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit

The DuPont Oval Logo, DuPont™ and all products denoted with ® or ™ are registered trademarks or trademarks of DuPont or its affiliates.